Joint-Development

Research partnerships are a critical element in the Life Sciences Industry.

Guilmot & Bassine has gained broad experience in drafting and reviewing joint-development agreements and we understand the importance of protecting the partners’ main asset, that is: their creativity. Hence, we take great care to clarify vital issues such as the non-disclosure, non-competition and exclusivity commitments and the ownership of background, side-ground, arising and post-ground IP and knowledge of our clients of all shapes and sizes.

We have profound discussions with our clients and are ready to address complex scientific issues to ensure that they delineate the proper scope of the background information they own to which access rights will be granted to the partners as this is needed for the execution of the project, for use after completion thereof or for use of the project’s arising IP.

Account is taken of the restriction to assignment or transfer of ownership in certain countries or when the development was financed through state or public monies.

Also, we particularly draw the attention of our emerging clients to the necessity of providing termination of license or reversion of rights in a situation where commercialization has not been pursued to enable further technological and commercial development.